Abstract:Leukocyte adhesion to vascular endothelium under flow involves an adhesion cascade consisting of multiple receptor pairs that may function in an overlapping fashion. P-selectin glycoprotein ligand-1 (PSGL-1) and L-selectin have been implicated in neutrophil adhesion to P- and E-selectin under flow conditions. To study, in isolation, the interaction of PSGL-1 with P-and E-selectin under flow, we developed an in vitro model in which various recombinant regions of extracellular PSGL-1 were coupled to 10-μm-diamet… Show more
“…Moreover, rupture-force histograms, representing the most probable rupture force at a given reproach velocity, always developed a single peak as opposed to regularly spaced force distributions, which would be indicative of the unbinding of oligomeric adhesions (Benoit et al, 2000). The observance of a single significant force histogram for E-selectin/PMN binding is particularly noteworthy, considering the evidence supporting E-selectin binding to glycosphingolipids on the leukocyte cell surface (Alon et al, 1995b;Burdick et al, 2001) as well as multiple regions on PSGL-1 (Goetz et al, 1997). Several distinct E-selectin ligands or simultaneous multiple binding regions might be revealed as a broadened histogram distribution or histograms with multiple peaks (Benoit et al, 2000).…”
Section: Resultsmentioning
confidence: 99%
“…PSGL-1 serves as the primary counter-receptor for P-and L-selectin, in that it selectively binds with relatively high affinity and removal or absence of PSGL-1 essentially abrogates P-or L-selectin-mediated rolling (Varki, 1997). E-selectin also binds effectively to PSGL-1 (Goetz et al, 1997;Li et al, 1996), but accumulating evidence supports the concept that glycosphingolipids might also be physiologically relevant Eselectin ligands (Alon et al, 1995a;Bochner et al, 1994;Burdick et al, 2001;Kobzdej et al, 2002). Dynamic rolling assays conducted in the presence of a blocking anti-PSGL-1 mAb (KPL-1) indicated that PSGL-1-coated microspheres are still capable of tethering on E-but not P-selectin substrates (Goetz et al, 1997), supporting the notion that PSGL-1 has binding sites for E-selectin other than the crucial 19 amino acid sequence recognized by KPL-1.…”
Section: Introductionmentioning
confidence: 99%
“…E-selectin also binds effectively to PSGL-1 (Goetz et al, 1997;Li et al, 1996), but accumulating evidence supports the concept that glycosphingolipids might also be physiologically relevant Eselectin ligands (Alon et al, 1995a;Bochner et al, 1994;Burdick et al, 2001;Kobzdej et al, 2002). Dynamic rolling assays conducted in the presence of a blocking anti-PSGL-1 mAb (KPL-1) indicated that PSGL-1-coated microspheres are still capable of tethering on E-but not P-selectin substrates (Goetz et al, 1997), supporting the notion that PSGL-1 has binding sites for E-selectin other than the crucial 19 amino acid sequence recognized by KPL-1. Along these lines, E-selectin appears to be capable of binding to N-linked oligosaccharides, including those found on PSGL-1 (Aeed et al, 2001;Patel et al, 1994;Vestweber, 1996).…”
Leukocytes are recruited from the bloodstream to sites of inflammation by the selectin family of adhesion receptors. In vivo and in vitro studies reveal distinctive rolling velocities of polymorphonuclear leukocytes over E-, P- and L-selectin substrates. The kinetic and mechanical properties of the selectin-ligand bonds responsible for these differences at the single-molecule level are not well understood. Using single-molecule force spectroscopy, we probe in situ the rupture force, unstressed off-rate and reactive compliance of single selectin receptors to single ligands on whole human polymorphonuclear leukocytes (PMNs) under conditions that preserve the proper orientation and post-translational modifications of the selectin ligands. Single L-selectin bonds to PMNs were more labile than either E- or P-selectin in the presence of an applied force. This outcome, along with a higher unstressed off-rate and a higher reactive compliance, explain the faster L-selectin-mediated rolling. By quantifying binding frequency in the presence of a specific blocking monoclonal antibody or following enzyme treatment, we determined that P-selectin glycoprotein ligand-1 is a high-affinity ligand for E-selectin on PMNs under force. The rupture force spectra and corresponding unstressed off-rate and reactive compliance of selectin-ligand bonds provide mechanistic insights that might help to explain the variable rolling of leukocytes over different selectin substrates.
“…Moreover, rupture-force histograms, representing the most probable rupture force at a given reproach velocity, always developed a single peak as opposed to regularly spaced force distributions, which would be indicative of the unbinding of oligomeric adhesions (Benoit et al, 2000). The observance of a single significant force histogram for E-selectin/PMN binding is particularly noteworthy, considering the evidence supporting E-selectin binding to glycosphingolipids on the leukocyte cell surface (Alon et al, 1995b;Burdick et al, 2001) as well as multiple regions on PSGL-1 (Goetz et al, 1997). Several distinct E-selectin ligands or simultaneous multiple binding regions might be revealed as a broadened histogram distribution or histograms with multiple peaks (Benoit et al, 2000).…”
Section: Resultsmentioning
confidence: 99%
“…PSGL-1 serves as the primary counter-receptor for P-and L-selectin, in that it selectively binds with relatively high affinity and removal or absence of PSGL-1 essentially abrogates P-or L-selectin-mediated rolling (Varki, 1997). E-selectin also binds effectively to PSGL-1 (Goetz et al, 1997;Li et al, 1996), but accumulating evidence supports the concept that glycosphingolipids might also be physiologically relevant Eselectin ligands (Alon et al, 1995a;Bochner et al, 1994;Burdick et al, 2001;Kobzdej et al, 2002). Dynamic rolling assays conducted in the presence of a blocking anti-PSGL-1 mAb (KPL-1) indicated that PSGL-1-coated microspheres are still capable of tethering on E-but not P-selectin substrates (Goetz et al, 1997), supporting the notion that PSGL-1 has binding sites for E-selectin other than the crucial 19 amino acid sequence recognized by KPL-1.…”
Section: Introductionmentioning
confidence: 99%
“…E-selectin also binds effectively to PSGL-1 (Goetz et al, 1997;Li et al, 1996), but accumulating evidence supports the concept that glycosphingolipids might also be physiologically relevant Eselectin ligands (Alon et al, 1995a;Bochner et al, 1994;Burdick et al, 2001;Kobzdej et al, 2002). Dynamic rolling assays conducted in the presence of a blocking anti-PSGL-1 mAb (KPL-1) indicated that PSGL-1-coated microspheres are still capable of tethering on E-but not P-selectin substrates (Goetz et al, 1997), supporting the notion that PSGL-1 has binding sites for E-selectin other than the crucial 19 amino acid sequence recognized by KPL-1. Along these lines, E-selectin appears to be capable of binding to N-linked oligosaccharides, including those found on PSGL-1 (Aeed et al, 2001;Patel et al, 1994;Vestweber, 1996).…”
Leukocytes are recruited from the bloodstream to sites of inflammation by the selectin family of adhesion receptors. In vivo and in vitro studies reveal distinctive rolling velocities of polymorphonuclear leukocytes over E-, P- and L-selectin substrates. The kinetic and mechanical properties of the selectin-ligand bonds responsible for these differences at the single-molecule level are not well understood. Using single-molecule force spectroscopy, we probe in situ the rupture force, unstressed off-rate and reactive compliance of single selectin receptors to single ligands on whole human polymorphonuclear leukocytes (PMNs) under conditions that preserve the proper orientation and post-translational modifications of the selectin ligands. Single L-selectin bonds to PMNs were more labile than either E- or P-selectin in the presence of an applied force. This outcome, along with a higher unstressed off-rate and a higher reactive compliance, explain the faster L-selectin-mediated rolling. By quantifying binding frequency in the presence of a specific blocking monoclonal antibody or following enzyme treatment, we determined that P-selectin glycoprotein ligand-1 is a high-affinity ligand for E-selectin on PMNs under force. The rupture force spectra and corresponding unstressed off-rate and reactive compliance of selectin-ligand bonds provide mechanistic insights that might help to explain the variable rolling of leukocytes over different selectin substrates.
“…Previous reports have described the N-glycans on PSGL-1 as dispensable for binding [28] and a considerable body of evidence suggest that the selectins bind to Olinked oligosaccharide structures on PSGL-1 [7][8][9][10], [14]. A specific threonine residue has been identified in the NH2-terminal portion of PSGL-1 that is believed to carry the (O-linked) ligand oligosac-charide recognized by P-selectin [29][30][31]. Moreover, results from recent investigations clearly demonstrate that a significant portion of the O-linked structures on PSGL-1 are fucosylated [18], [19], thereby lending further support the involvement of O-linked oligosaccharides in selectin binding.…”
PSGL-1, a specific ligand for P-, E-and L-selectin, was isolated from in vivo [ 3 H]-glucosamine labeled HL-60 cells by a combination of wheat germ agglutinin-agarose and P-or E-selectin-agarose chromatography. N-linked oligosaccharides were released from the purified, denatured ligand molecule by peptide: N-glycosidase F treatment and, following separation by Sephacryl S-200 chromatography, partially characterized using lectin, ion-exchange and size-exclusion chromatography in combination with glycosidase digestions. The data obtained suggest that the N-glycans on PSGL-1 are predominantly core-fucosylated, multiantennary complex type structures with extended, poly-N-acetyllactosamine containing outer chains. A portion of the outer chains appears to be substituted with fucose indicating that the N-glycans, in addition to the Oglycans on PSGL-1, may be involved in selectin binding.
“…One strategy for studying the contributions of individual components of that surface is to coat artificial microspheres with purified or recombinant versions of molecules of interest. We and others have used this strategy in the past to investigate the capacity of PSGL-1 and other adhesion molecules to mediate rolling in vitro [27][28][29][30] and in vivo. 20,22,31 Ideally, the properties (size, ligand density, deformabilty, and so forth) of microspheres used for such investigations will closely match those of leukocytes, allowing direct comparisons to be made.…”
P-selectin glycoprotein ligand-1 (PSGL-1) binding to Pselectin controls early leukocyte rolling during inflammation. Interestingly, antibodies and pharmacological inhibitors (eg, rPSGL-Ig) that target the N-terminus of PSGL-1 reduce but do not abolish P-selectin-dependent leukocyte rolling in vivo whereas PSGL-1-deficient mice have almost no P-selectin-dependent rolling. We have investigated mechanisms of P-selectin-dependent, PSGL-1-independent rolling using intravital microscopy. Initially we used fluorescent microspheres to study the potential of L-selectin and the minimal selectin ligand sialyl Lewis x (sLe x ) to interact with postcapillary venules in the absence of PSGL-1. Microspheres coated with combinations of L-selectin and sLe x interacted with surgically stimulated cremaster venules in a P-selectin-dependent manner. Microspheres coated with either L-selectin or sLe x alone showed less evidence of interaction. We also investigated leukocyte rolling in the presence of PSGL-1 antibody or inhibitor (rPSGL-Ig), both of which partially inhibited P-selectin-dependent leukocyte rolling. Residual rolling was substantially inhibited by L-selectin-blocking antibody or a previously described sLe x mimetic (CGP69669A). Together these data suggest that leukocytes can continue to roll in the absence of optimal P-selectin/PSGL-1 interaction using an alternative mechanism that involves P-selectin-, L-selectin-, and sLe and present attractive targets for anti-inflammatory drugs. P-Selectin may be a good target for cardiovascular disease therapy, 2-5 although notable clinical trial disappointments 6,7 suggest that effective P-selectin inhibition may be more challenging than expected.Natural ligand mimicry is a common drug development approach. Elements of PSGL-1 required for high-affinity P-selectin recognition include a sialylated, fucosylated O-glycan and tyrosine sulfation at appropriate positions near the N-terminus. 8 Drugs mimicking one or more of these elements could theoretically inhibit P-selectin. Inhibitors based on the carbohydrate selectin ligand, sLe x , are effective, albeit in high doses, against E-selectindependent leukocyte rolling in vivo but have no measurable effect on established P-selectin-dependent rolling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.